Senti Biosciences Inc (SNTI) — Financial Flexibility Index
Senti Biosciences Inc (SNTI) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of $-9.45 Million (operating CF $-9.45 Million minus capex $0.00) represents 0% of total liabilities ($44.56 Million). Check SNTI tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Senti Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Senti Biosciences Inc across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Senti Biosciences Inc.
Annual Financial Flexibility Index for Senti Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Senti Biosciences Inc. Explore Senti Biosciences Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.57x | $-41.37 Million | $-41.40 Million | $72.19 Million | ▲ +25.3% |
| 2023 | -0.77x | $-40.36 Million | $-52.40 Million | $52.57 Million | ▼ -734.3% |
| 2022 | 0.12x | $6.48 Million | $-34.90 Million | $53.53 Million | ▲ +115.1% |
| 2021 | -0.80x | $-29.09 Million | $-34.63 Million | $36.33 Million | ▼ -272.6% |
| 2020 | -0.21x | $-23.01 Million | $-24.17 Million | $107.06 Million | ▲ +76.5% |
| 2019 | -0.92x | $-16.38 Million | $-18.38 Million | $17.88 Million | — |